Topic
Oncology
20 published works
Big Molecule Watch
Armed Cell Therapeutics Acquires Preclinical CAR-T Portfolio from Lakefront
On October 14, 2026, Armed Cell Therapeutics BV (“Armed Cell”) announced that it acquired a portfolio of preclinical CAR-T assets from Lakefront Biotherapeutics NV (“Lakefront”), formerly Galapagos NV. The two…
Big Molecule Watch
STADA and SBP Group Launch Biosimilars Partnership
STADA and Sino Biopharmaceutical Limited (“SBP Group”), through its subsidiary Chia Tai Tianqing Pharmaceutical Group (“CTTQ”), have entered into a partnership to manufacture, market, and sell biosimilars. CTTQ will develop,…
Big Molecule Watch
BioNTech Acquires Biotheus To Boost Oncology Strategy
By Tara Thigpen
On February 3, 2025, BioNTech SE (“BioNTech”) confirmed the completion of its acquisition of biotechnology company Biotheus for an upfront payment of $800 million and up to $150 million in…
Big Molecule Watch
Teva and mAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership
On October 3, 2024, Teva Pharmaceuticals and mAbxience, a Fresenius Kabi majority-owned group, announced a new global licensing agreement for the development of an anti PD-1 oncology biosimilar candidate, further…
Health Care Law Today
Enhancing Oncology Model – Successor to Oncology Care Model: What’s New
By Adria Warren, Alexis Finkelberg Bortniker, Kinal M. Patel
Thank you to co-author Danny Costandy, a summer associate in Foley's San Diego office, for his contributions to this post. The Center for Medicare and Medicaid Innovation (CMMI) is launching…
Big Molecule Watch
Pfizer Acquires Biologics Company To Expand Its Oncology Pipeline
Last week, Pfizer announced that it will acquire Trillium Therapeutics, a clinical stage immune-oncology company based in Cambridge, Massachusetts. Under the agreement, Pfizer reported that it “will acquire all outstanding…
Health Care Law Today
ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS): Positive Disruption in the COVID-19 ERA – Part 3
By Adria Warren, Alexis Finkelberg Bortniker
The ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. The Summit serves the prominent thought leadership forum and annual conference on matters of…
Health Care Law Today
ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS): Positive Disruption in the COVID-19 ERA – Part 2
By Adria Warren, Alexis Finkelberg Bortniker
The ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. Through a combination of five-star panels and interactive drop-in sessions, attendees learned about key…
Big Molecule Watch
NCCN and Pfizer Announce New Biosimilars Research Projects in Oncology
The National Comprehensive Cancer Network® (NCCN) Oncology Research Program (ORP) in collaboration with Pfizer announced this week a list of ten selected organizations and their research projects that have been…
Bill Madden's Blog
Conduct: Naturopathy / Oncology.
By Bill Madden
In Malaguti v Orchard [2020] QDC 242 (on AUSTLII) the Court was required to consider an appeal from convictions of the appellant before a Magistrate, for offences under the Health…